Drug: KALETRA Injury: Foetal exposure during pregnancy Quarter: 2016Q3
Total Records: 27 Number of Pages: 2
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 39965834 | KALETRA | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 DY | M | 2 KG | 20160826 | FR |
| 57695837 | KALETRA | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 1.00 DY | M | 2 KG | 20160825 | US |
| 73285784 | KALETRA | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | 0 | 20160705 | US | |
| 74083893 | KALETRA | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | F | 0 | 20160824 | FR |
| 90604953 | KALETRA | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | 0 | 20160826 | FR | |
| 117055442 | KALETRA | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | 0 | 20160819 | FR | |
| 118548992 | KALETRA | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 DY | F | 2 KG | 20160901 | US |
| 118687852 | KALETRA | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 1.00 DY | F | 3 KG | 20160901 | US |
| 118698072 | KALETRA | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 DY | M | 2 KG | 20160825 | US |
| 118777302 | KALETRA | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 DY | M | 1 KG | 20160826 | US |
| 118942172 | KALETRA | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 1.00 DY | M | 3 KG | 20160826 | US |
| 119150422 | KALETRA | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 DY | F | 1 KG | 20160826 | US |
| 125224641 | KALETRA | Foetal exposure during pregnancy | GLAXOSMITHKLINE | 0.00 | M | 3 KG | 20160701 | COUNTRY NOT SPECIFIED |
| 125272611 | KALETRA | Foetal exposure during pregnancy | VIIV | 0.00 | M | 3 KG | 20160705 | COUNTRY NOT SPECIFIED |
| 126351093 | KALETRA | Foetal exposure during pregnancy | ABBVIE | 0.00 | 0 | 20160825 | COUNTRY NOT SPECIFIED | |
| 126886844 | KALETRA | Foetal exposure during pregnancy | ABBVIE | 0.00 | M | 0 | 20160912 | COUNTRY NOT SPECIFIED |
| 127084261 | KALETRA | Foetal exposure during pregnancy | JANSSEN | 0.00 | 0 | 20160901 | US | |
| 127084271 | KALETRA | Foetal exposure during pregnancy | JANSSEN | 0.00 | 0 | 20160901 | US | |
| 127094381 | KALETRA | Foetal exposure during pregnancy | JANSSEN | 0.00 | 0 | 20160902 | US | |
| 127192992 | KALETRA | Foetal exposure during pregnancy | RANBAXY | 0.00 DY | M | 2 KG | 20160919 | US |
Total Records: 27 Number of Pages: 2